0001193125-23-297146.txt : 20231218 0001193125-23-297146.hdr.sgml : 20231218 20231218083153 ACCESSION NUMBER: 0001193125-23-297146 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20231218 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing FILED AS OF DATE: 20231218 DATE AS OF CHANGE: 20231218 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IMPEL PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001445499 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 263058238 STATE OF INCORPORATION: DE FISCAL YEAR END: 0426 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40353 FILM NUMBER: 231492310 BUSINESS ADDRESS: STREET 1: 201 ELLIOTT AVE. W STREET 2: SUITE 260 CITY: SEATTLE STATE: WA ZIP: 98119 BUSINESS PHONE: 206-568-1466 MAIL ADDRESS: STREET 1: 201 ELLIOTT AVE. W STREET 2: SUITE 260 CITY: SEATTLE STATE: WA ZIP: 98119 FORMER COMPANY: FORMER CONFORMED NAME: IMPEL NEUROPHARMA INC DATE OF NAME CHANGE: 20080917 8-K 1 d623942d8k.htm 8-K 8-K
IMPEL PHARMACEUTICALS INC false 0001445499 0001445499 2023-12-18 2023-12-18

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 18, 2023

 

 

IMPEL PHARMACEUTICALS INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-40353   26-3058238

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

201 Elliott Avenue West, Suite 260

Seattle, WA

  98119
(Address of principal executive offices)   (Zip Code)

(206) 568-1466

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
symbol(s)

 

Name of each exchange
on which registered

Common Stock, $0.001 Par Value Per Share   IMPL   The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 


Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

As previously disclosed, on April 11, 2023, Impel Pharmaceuticals, Inc. (the “Company”) received written notice (the “Delisting Notice”) from the staff of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that it did not meet the $15 million minimum market value of publicly held shares required to maintain continued listing as set forth in Nasdaq Marketplace Rule 5450(b)(2)(C) (the “MVPHS Rule”) for the 30-business day period ended April 5, 2023, and that, for the for the 30-business day period ended April 5, 2023, the Company had not met the $50 million minimum market value of listed securities required to maintain continued listing as set forth in Nasdaq Marketplace Rule 5450(b)(2)(A) (the “MVLS Rule” and together with the MVPHS Rule, the “Rules”). As provided in the Nasdaq rules, the Company had 180 calendar days, or until October 9, 2023, to regain compliance. The Company did not regain compliance with such applicable Rules prior to October 9, 2023, and on October 16, 2023, the Company requested a hearing to remain on Nasdaq, which request suspended such delisting determination until a decision is issued by Nasdaq. On December 14, 2023, the Company received a letter from Nasdaq advising the Company that that the Company’s common stock (the “Common Stock”) will be delisted from Nasdaq.

Accordingly, trading of the Company’s Common Stock will be suspended at the opening of business on December 18, 2023 and a Form 25-NSE will be filed with the Securities and Exchange Commission (the “SEC”), which will remove the Company’s Common Stock from listing and registration on Nasdaq. As a result, the Company’s Common Stock is expected to begin trading on the over-the-counter (“OTC”) market. No assurances can be made that trading of the Company’s Common Stock on the OTC will commence or be maintained.

Cautionary Statement Regarding Forward-Looking Statements

This filing contains “forward-looking” statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: “believe,” “may,” “will,” “potentially,” “estimate,” “continue,” “anticipate,” “intend,” “could,” “would,” “project,” “plan,” “expect” or the negative or plural of these words or similar expressions. These statements are subject to numerous risks and uncertainties that could cause actual results and events to differ materially from those anticipated by the forward-looking statements. Important factors that may cause actual results to differ materially from those in the forward-looking statements include, but are not limited to, risk factors described in the Company’s filings with the SEC, the Company’s ability to explore strategic alternatives, risk of the initiation of bankruptcy proceedings under Chapter 11 of the U.S. Bankruptcy Code by the Company, and risks related to preliminary financial results, including the risks that the preliminary financial results reported herein reflect information available to the Company only at this time and may differ from actual results, including in connection with the Company’s completion of financial closing procedures. The Company disclaims and does not undertake any obligation to update or revise any forward-looking statement in this report, except as required by applicable law or regulation.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    IMPEL PHARMACEUTICALS INC.
Date: December 18, 2023     By:  

/s/ Len Paolillo

      Len Paolillo
      Interim Chief Executive Officer
EX-101.SCH 2 impl-20231218.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 3 impl-20231218_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Entity Registrant Name Entity Registrant Name Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company Entity Ex Transition Period Entity Ex Transition Period EX-101.PRE 4 impl-20231218_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 5 R1.htm IDEA: XBRL DOCUMENT v3.23.4
Document and Entity Information
Dec. 18, 2023
Cover [Abstract]  
Entity Registrant Name IMPEL PHARMACEUTICALS INC
Amendment Flag false
Entity Central Index Key 0001445499
Document Type 8-K
Document Period End Date Dec. 18, 2023
Entity Incorporation State Country Code DE
Entity File Number 001-40353
Entity Tax Identification Number 26-3058238
Entity Address, Address Line One 201 Elliott Avenue West
Entity Address, Address Line Two Suite 260
Entity Address, City or Town Seattle
Entity Address, State or Province WA
Entity Address, Postal Zip Code 98119
City Area Code (206)
Local Phone Number 568-1466
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, $0.001 Par Value Per Share
Trading Symbol IMPL
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Entity Ex Transition Period false
XML 6 d623942d8k_htm.xml IDEA: XBRL DOCUMENT 0001445499 2023-12-18 2023-12-18 IMPEL PHARMACEUTICALS INC false 0001445499 8-K 2023-12-18 DE 001-40353 26-3058238 201 Elliott Avenue West Suite 260 Seattle WA 98119 (206) 568-1466 false false false false Common Stock, $0.001 Par Value Per Share IMPL NASDAQ true false EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.4 html 1 24 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://impelnp.com//20231218/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d623942d8k.htm impl-20231218.xsd impl-20231218_lab.xml impl-20231218_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "d623942d8k.htm": { "nsprefix": "impl", "nsuri": "http://impelnp.com/20231218", "dts": { "inline": { "local": [ "d623942d8k.htm" ] }, "schema": { "local": [ "impl-20231218.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd" ] }, "labelLink": { "local": [ "impl-20231218_lab.xml" ] }, "presentationLink": { "local": [ "impl-20231218_pre.xml" ] } }, "keyStandard": 24, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 3, "http://xbrl.sec.gov/dei/2023": 3 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 25, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 24 }, "report": { "R1": { "role": "http://impelnp.com//20231218/taxonomy/role/DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "duration_2023-12-18_to_2023-12-18", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d623942d8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "duration_2023-12-18_to_2023-12-18", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d623942d8k.htm", "first": true, "unique": true } } }, "tag": { "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://impelnp.com//20231218/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security 12b Title", "terseLabel": "Security 12b Title", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://impelnp.com//20231218/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://impelnp.com//20231218/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://impelnp.com//20231218/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://impelnp.com//20231218/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "terseLabel": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://impelnp.com//20231218/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://impelnp.com//20231218/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "terseLabel": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://impelnp.com//20231218/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://impelnp.com//20231218/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "terseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://impelnp.com//20231218/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "terseLabel": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://impelnp.com//20231218/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "terseLabel": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://impelnp.com//20231218/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://impelnp.com//20231218/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://impelnp.com//20231218/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://impelnp.com//20231218/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r7" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://impelnp.com//20231218/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://impelnp.com//20231218/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "terseLabel": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://impelnp.com//20231218/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "terseLabel": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://impelnp.com//20231218/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "terseLabel": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://impelnp.com//20231218/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://impelnp.com//20231218/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://impelnp.com//20231218/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "terseLabel": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://impelnp.com//20231218/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "terseLabel": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://impelnp.com//20231218/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 14 0001193125-23-297146-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-23-297146-xbrl.zip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end